Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | salsolidin | 164752 | drug-path |
| ErbB signaling pathway | R-HSA-168638 | map04012 | salsolidin | 164752 | drug-path |
| Type II diabetes mellitus | R-HSA-2127377 | map04930 | salsolidin | 164752 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | salsolidin | 164752 | drug-path |
| Vibrio cholerae infection | R-HSA-9609646 | map05110 | salsolidin | 164752 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | salsolidin | 164752 | drug-path |
| Mismatch repair | R-HSA-5358508 | map03430 | salsolidin | 164752 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | salsolidin | 164752 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | salsolidin | 164752 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | thiostrepton | 16154490 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | thiostrepton | 16154490 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | thiostrepton | 16154490 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | thiostrepton | 16154490 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | thiostrepton | 16154490 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | thiostrepton | 16154490 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | thiostrepton | 16154490 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | thiostrepton | 16154490 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | thiostrepton | 16154490 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | thiostrepton | 16154490 | drug-path |
| Acute myeloid leukemia | R-HSA-9680350 | map05221 | thiostrepton | 16154490 | drug-path |